<DOC>
	<DOC>NCT01861704</DOC>
	<brief_summary>Randomized post market study comparing Lyric to Lyric2 capturing information regarding comparative performance and safety.</brief_summary>
	<brief_title>Post-market Study to Capture Information Regarding Performance of Lyric2</brief_title>
	<detailed_description>Randomized post market study comparing extended wear hearing aids Lyric to Lyric2 capturing information regarding comparative performance and safety.</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<criteria>Aged 1890 years at the time of enrollment in the study Mild to moderatelysevere hearing loss bilaterally, or unilaterally if normal hearing in other ear Fluent in English Willingness to comply with all study requirements Scuba dives or sky dives Underwater swimming or dives into the water Handicaps that would restrict participation in all the evaluations Hearing loss of neural or central origin Unrealistic expectations regarding benefits and limitations inherent in the devices Chemotherapy within the last six months Compromised immune system Radiation to head or neck Perforated tympanic membrane History of cholesteatoma Active outer or middle ear pathology High levels of anticoagulant therapy Insulindependent and/or uncontrolled diabetes Contact dermatitis Bleeding disorder Unwillingness or inability to comply with all study requirements</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Mild to moderate hearing loss</keyword>
</DOC>